Fujita Kazutoshi, Uemura Motohide, Yamamoto Yoshiyuki, Tanigawa Go, Nakata Wataru, Sato Mototaka, Nagahara Akira, Kiuchi Hiroshi, Nakai Yasutomo, Matsumiya Kiyomi, Yamaguchi Seiji, Nonomura Norio
Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan,
Int J Clin Oncol. 2015 Feb;20(1):156-63. doi: 10.1007/s10147-014-0695-1. Epub 2014 Apr 18.
This study aimed to identify preoperative parameters for predicting cancer-specific survival (CSS) in patients with upper urinary tract urothelial carcinoma (UTUC) who have undergone radical nephroureterectomy (RNU).
The preoperative clinical and laboratory records of 357 UTUC patients who underwent RNU at three different institutions were retrospectively reviewed (256, training set; 101, test set). Univariate and multivariate analyses were performed on the training set data to identify preoperative prognostic factors, using which a risk stratification model was developed. The model was validated using test set data.
In univariate analysis, clinical T stage classification and preoperative concentrations of hemoglobin, C-reactive protein, sodium, and albumin showed significant association with CSS. Multivariate analysis showed that low preoperative sodium and hemoglobin concentrations were significantly associated with a poor prognosis. A risk stratification model was developed using the preoperative sodium (<141 mEq/L) and hemoglobin concentrations (below normal). Three subgroups were formed depending on the presence of no (favorable group), one (intermediate), or two (poor) prognostic factors, and the 5-year CSS estimates were found to be 96.5, 75.5, and 47.0 %, respectively (P < 0.01). The risk model was significantly associated with the adverse pathological findings of stage pT3 or more and lymphovascular invasion (P = 0.005).
We identified low preoperative sodium and hemoglobin concentrations as prognostic factors for patients with UTUC treated with RNU. Our risk stratification model may help physicians design a therapeutic strategy.
本研究旨在确定接受根治性肾输尿管切除术(RNU)的上尿路尿路上皮癌(UTUC)患者术前预测癌症特异性生存(CSS)的参数。
回顾性分析了在三个不同机构接受RNU的357例UTUC患者的术前临床和实验室记录(256例为训练集;101例为测试集)。对训练集数据进行单因素和多因素分析以确定术前预后因素,并据此建立风险分层模型。使用测试集数据对该模型进行验证。
在单因素分析中,临床T分期分类以及术前血红蛋白、C反应蛋白、钠和白蛋白浓度与CSS显著相关。多因素分析显示,术前低钠和低血红蛋白浓度与预后不良显著相关。利用术前钠浓度(<141 mEq/L)和血红蛋白浓度(低于正常)建立了风险分层模型。根据无(良好组)、一个(中间组)或两个(不良组)预后因素的存在情况形成三个亚组,发现5年CSS估计值分别为96.5%、75.5%和47.0%(P<0.01)。风险模型与pT3期或更高分期以及淋巴管浸润的不良病理结果显著相关(P=0.005)。
我们确定术前低钠和低血红蛋白浓度是接受RNU治疗的UTUC患者的预后因素。我们的风险分层模型可能有助于医生设计治疗策略。